Synonyms:
Status: Phase 2
Entry Type: Antibody
Molecule Category: UNKNOWN
UNII: RA1Z27KVB0

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Interleukin-33 inhibitor

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Dermatitis, Atopic 2 D003876 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL4650487
FDA SRS RA1Z27KVB0